Presentation TCT 2016 Case Presentation: Evaluation and Management of Recurrent DES Restenosis Presenter: Fernando Alfonso, Stephan Windecker, Adnan K. Chhatriwalla October 30, 2016
Presentation TCT 2016 Is Brachytherapy the Best Last Hope for Recurrent DES Restenosis? Presenter: Fernando Alfonso, Stephan Windecker, Ron Waksman October 30, 2016
Presentation TCT 2016 Prognosis and Treatment Options for DES Restenosis and Re-restenosis Presenter: Fernando Alfonso, Stephan Windecker October 30, 2016
Presentation TCT 2016 Case Presentation: A Surprise in the Evaluation and Management of Stent Thrombosis Presenter: Fernando Alfonso, Stephan Windecker, Ehrin J. Armstrong October 30, 2016
Presentation TCT 2016 How to Evaluate and Treat the Patient With Metallic Stent Thrombosis: The Usual Suspects and Beyond Presenter: Fernando Alfonso, Stephan Windecker, Giulio G. Stefanini October 30, 2016
Presentation TCT 2016 Are All Stent Thromboses Prognostically Created Equal? Impact of Original Clinical Presentation, Stent Location and Thrombosis Timing Presenter: Fernando Alfonso, Stephan Windecker, Robert-Jan van Geuns October 30, 2016
Presentation TCT 2016 Is the OCT-derived Healing Score A Meaningful Metric to Evaluate Stent Safety? Presenter: Fernando Alfonso, Stephan Windecker, Giulio Guagliumi October 30, 2016
Presentation TCT 2016 OCT-assessed Rate of Early Strut Coverage: Differences Between DES and Its Implications Presenter: Fernando Alfonso, Stephan Windecker, Stephen WL Lee October 30, 2016
Presentation TCT 2016 Is Acute or Late Acquired Malapposition By IVUS or OCT A Risk Factor for Stent Thrombosis? Presenter: Fernando Alfonso, Stephan Windecker, Gary S. Mintz October 30, 2016
Presentation TCT 2016 New Insights Into the Mechanisms and Patterns of in-stent Restenosis in BMS and DES Evaluated By IVUS and OCT (With Case Examples) Presenter: Fernando Alfonso, Stephan Windecker, Akiko Maehara October 30, 2016
Presentation TCT 2016 Neoatherosclerosis as A Cause of Very Late DES Failure: Insights From Multimodality Imaging Studies Presenter: Fernando Alfonso, Stephan Windecker, Yasunori Ueda October 30, 2016
Presentation TCT 2016 Can Improvements in Metallurgy and Stent Design Improve Early and Late Outcomes With DES? Presenter: Fernando Alfonso, Stephan Windecker, Elazer R. Edelman October 30, 2016
Presentation TCT 2016 Mechanisms of Late and Very Late Restenosis: Is Improved Technology the Answer? Presenter: Fernando Alfonso, Stephan Windecker, Juan F. Granada October 30, 2016
Presentation TCT 2016 Pathologic Insights Into Vascular Healing and the Causes of Stent Thrombosis and Restenosis: Are We Making Progress as Stents Evolve? Presenter: Fernando Alfonso, Stephan Windecker, Aloke V. Finn October 30, 2016
Presentation TCT 2016 Very Late Failures After Metallic DES: Frequency and Clinical Predictors Presenter: Fernando Alfonso, Stephan Windecker, Mahesh V Madhavan October 30, 2016
Presentation TCT 2016 Treatment of In-Stent Restenosis Presenter: Teguh Santoso, Wasan Udayachalerm October 30, 2016
Presentation TCT 2016 Denmark Presents: A Case of Restenosis in the Left Main Bifurcation Presenter: Thomas Engstroem, Hyo-Soo Kim, Samer Mansour, Quang Ngoc Nguyen, Jens Flensted Lassen October 30, 2016
Presentation TCT 2016 Restenosis and Stent Thrombosis: Frequency, Predictors, and Treatments Presenter: George D. Dangas, Rajesh V Swaminathan October 30, 2016
Presentation TCT 2016 Case #2: Recurrent SVG-LAD In-Stent Restenosis With LMCA CTO and Low EF Presenter: Barry D. Rutherford, Gerard T. Wilkins, James M. McCabe October 30, 2016
News Conference News TCT 2016 ‘Worrisome’ 3-Year Data From ABSORB II Raise Concerns About First-Generation Bioresorbable Stent Michael O'Riordan October 30, 2016